Caveolin 3 (CAV3) Peptide
CAV3
Reactivité: Humain
Hôte: Synthetic
BP, IHC, WB
-
- Antigène Tous les produits Caveolin 3 (CAV3)
- Caveolin 3 (CAV3)
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CAV3 antibody (Catalog #: AVARP09021_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
Caveolin 3 (CAV3) peptide
CAV3 Reactivité: Humain, Rat, Souris, Boeuf (Vache), Chien, Porc Hôte: Synthetic BP, Imm
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- Caveolin 3 (CAV3)
- Synonymes
- LGMD1C Peptide, LQT9 Peptide, VIP-21 Peptide, VIP21 Peptide, AI385751 Peptide, Cav-3 Peptide, M-cav Peptide, caveolin-3 Peptide, im:6902906 Peptide, zgc:109710 Peptide, LOC733765 Peptide, CAV3 Peptide, cav3 Peptide, caveolin 3 Peptide, caveolin-3 Peptide, CAV3 Peptide, Cav3 Peptide, cav3 Peptide, LOC733765 Peptide, cav-3 Peptide
- Sujet
-
CAV3 is a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.
Alias Symbols: LQT9, VIP21, LGMD1C, VIP-21
Protein Interaction Partner: DAG1,DYSF,EGFR,GNAS,INSR,JPH2,NOS1,PFKM,SLC22A11,SLC8A1,DAG1,DYSF,EGFR,JPH2,PDGFRA,PDGFRB,PFKM,SLC8A1
Protein Size: 151 - Poids moléculaire
- 17 kDa
- ID gène
- 859
- NCBI Accession
- NM_001234, NP_001225
- UniProt
- P56539
-
Vous êtes ici:
